Teenage mutant neutrophilic precursors: Leukemia cutis with IDH2 mutation on enasidenib therapy

被引：4
|
作者：
Kallen, Michael E. [1 ]
Koka, Rima [1 ]
Singh, Zeba [1 ]
Sanchez-Petitto, Gabriela [2 ]
Zaman, Qamar U. [3 ]
Yared, Jean A. [2 ]
Duong, Vu H. [2 ]
机构：
[1] Univ Maryland, Sch Med, Dept Pathol, 22 S Greene St,NBW-54, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med, Div Hematol Oncol, Baltimore, MD 21201 USA
[3] Univ Pittsburgh, Med Ctr, Western Maryland, Cumberland, MD USA
来源：
LEUKEMIA RESEARCH | 2020年 / 96卷
关键词：
DIFFERENTIATION SYNDROME;
D O I：
10.1016/j.leukres.2020.106406
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy
    Venugopal, Sangeetha
    Takahashi, Koichi
    Daver, Naval
    Maiti, Abhishek
    Borthakur, Gautam
    Loghavi, Sanam
    Short, Nicholas J.
    Ohanian, Maro
    Masarova, Lucia
    Issa, Ghayas
    Wang, Xuemei
    Carlos, Bueso-Ramos
    Yilmaz, Musa
    Kadia, Tapan
    Andreeff, Michael
    Ravandi, Farhad
    Konopleva, Marina
    Kantarjian, Hagop M.
    DiNardo, Courtney D.
    BLOOD CANCER JOURNAL, 2022, 12 (01)
  • [42] Enasidenib Is Highly Active in Previously Untreated IDH2 Mutant AML: Early Results from the Beat AML Master Trial
    Stein, Eytan M.
    Shoben, Abigail
    Borate, Uma
    Baer, Maria R.
    Stock, Wendy
    Patel, Prapti A.
    Kovacsovics, Tibor
    Blum, William
    Vergilio, Jo-Anne
    Heerema, Nyla A.
    Rosenberg, Leonard
    Marcus, Sonja
    Stefanos, Mona
    Chervin, Jordan
    Druker, Brian J.
    Burd, Amy
    Byrd, John C.
    Levine, Ross L.
    Mims, Alice S.
    BLOOD, 2018, 132
  • [43] Differentiation Syndrome in a Patient with Non-Small-Cell Lung Cancer Harboring IDH2 Mutation Treated with Enasidenib
    Sukhadia, B.
    Tan, D.
    Oh, Y.
    Chae, Y. K.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S407 - S408
  • [44] Health-Related Quality of Life (HRQoL) during Treatment with Enasidenib (ENA) Plus Azacitidine (AZA) in Patients with Newly Diagnosed Mutant IDH2 (m IDH2) Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy (IC)
    DiNardo, Courtney D.
    Dohner, Hartmut
    Zeidan, Amer M.
    Schuh, Andre C.
    Vyas, Paresh
    Stein, Eytan M.
    Wei, Andrew H.
    de Botton, Stephane
    Chen, Clara
    Lord-Bessen, Jennifer
    Martin-Regueira, Patricia
    Lersch, Frederik
    Gong, Jing
    Guo, Shien
    Shi, Ling
    Montesinos, Pau
    BLOOD, 2021, 138
  • [45] Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy
    Sangeetha Venugopal
    Koichi Takahashi
    Naval Daver
    Abhishek Maiti
    Gautam Borthakur
    Sanam Loghavi
    Nicholas. J. Short
    Maro Ohanian
    Lucia Masarova
    Ghayas Issa
    Xuemei Wang
    Bueso-Ramos Carlos
    Musa Yilmaz
    Tapan Kadia
    Michael Andreeff
    Farhad Ravandi
    Marina Konopleva
    Hagop M. Kantarjian
    Courtney D. DiNardo
    Blood Cancer Journal, 12
  • [46] IDH2 mutations in acute myeloid leukemia
    Babakhanlou, Rodrick
    DiNardo, Courtney
    Borthakur, Gautam
    LEUKEMIA & LYMPHOMA, 2023, 64 (11) : 1733 - 1741
  • [47] IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome
    Lin, Jiang
    Yao, Dong-ming
    Qian, Jun
    Chen, Qin
    Qian, Wei
    Li, Yun
    Yang, Jing
    Wang, Cui-zhu
    Chai, Hai-yan
    Qian, Zhen
    Xiao, Gao-fei
    Xu, Wen-rong
    ANNALS OF HEMATOLOGY, 2012, 91 (04) : 519 - 525
  • [48] IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome
    Jiang Lin
    Dong-ming Yao
    Jun Qian
    Qin Chen
    Wei Qian
    Yun Li
    Jing Yang
    Cui-zhu Wang
    Hai-yan Chai
    Zhen Qian
    Gao-fei Xiao
    Wen-rong Xu
    Annals of Hematology, 2012, 91 : 519 - 525
  • [49] Astrocytoma, IDH-mutant, CNS WHO grade 3 with novel non-canonical IDH2 mutation
    Auen, T.
    Shonka, N.
    Chen, J.
    Cathcart, S.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 83 (06): : 498 - 499
  • [50] Mutational analysis for IDH1 and IDH2 in pediatric leukemia
    Hiwatari, Mitsuteru
    Takita, Junko
    Nishimura, Riki
    Okubo, Jun
    Oki, Kentaro
    Sanada, Masashi
    Sotomatsu, Manabu
    Kikuchi, Akira
    Igarashi, Takashi
    Hayashi, Yasuhide
    Ogawa, Seishi
    CANCER RESEARCH, 2012, 72
12345